WO2011145909A3 - 판두라틴 유도체 또는 보에센베르기아 판두라타 추출물의 근육 증가 촉진, 항-피로 및 운동수행능력 향상에 관한 새로운 용도 - Google Patents

판두라틴 유도체 또는 보에센베르기아 판두라타 추출물의 근육 증가 촉진, 항-피로 및 운동수행능력 향상에 관한 새로운 용도 Download PDF

Info

Publication number
WO2011145909A3
WO2011145909A3 PCT/KR2011/003735 KR2011003735W WO2011145909A3 WO 2011145909 A3 WO2011145909 A3 WO 2011145909A3 KR 2011003735 W KR2011003735 W KR 2011003735W WO 2011145909 A3 WO2011145909 A3 WO 2011145909A3
Authority
WO
WIPO (PCT)
Prior art keywords
muscle mass
extract
mass growth
exercise performance
fatigue
Prior art date
Application number
PCT/KR2011/003735
Other languages
English (en)
French (fr)
Other versions
WO2011145909A2 (ko
Inventor
황재관
김도언
Original Assignee
(주)바이오케어
(주)뉴트리
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by (주)바이오케어, (주)뉴트리 filed Critical (주)바이오케어
Priority to JP2013511120A priority Critical patent/JP5905874B2/ja
Priority to EP11783791.4A priority patent/EP2572710B1/en
Priority to CN201180029079.5A priority patent/CN103037854B/zh
Publication of WO2011145909A2 publication Critical patent/WO2011145909A2/ko
Publication of WO2011145909A3 publication Critical patent/WO2011145909A3/ko
Priority to US13/682,216 priority patent/US9198880B2/en
Priority to US14/846,204 priority patent/US9452193B2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50—Methods involving additional extraction steps

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Fodder In General (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

본 발명은 판두라틴 유도체 또는 보에센베르기아 판두라타 추출물의 근육 증가 촉진, 항-피로 및 운동수행능력 향상에 관한 새로운 용도에 관한 것으로, 보다 상세하게는 판두라틴 유도체 또는 이의 염 또는 보에센베르기아 판두라타 추출물을 유효성분으로 포함하고, 근육 증강 및 피로 회복을 촉진하여 운동성을 증진시키는 운동수행능력 향상, 근육 증가 촉진 및 항-피로용 조성물, 판두라틴 유도체 또는 이의 염 또는 보에센베르기아 판두라타 추출물을 이를 필요로 하는 개체에 투여하는 운동수행능력 향상, 근육 증가 촉진 및 항-피로 방법 등에 관한 것이다. 본 발명의 판두라틴 유도체 또는 보에센베르기아 판두라타 추출물은 부작용 없이 안전하게 사용할 수 았고, 근육 내 PPAR δ의 발현을 증가시켜 근육량 증가, 피로회복 및 운동성 증가 등 운동수행능력 향상에 우수한 효과를 가진다.
PCT/KR2011/003735 2010-05-20 2011-05-20 판두라틴 유도체 또는 보에센베르기아 판두라타 추출물의 근육 증가 촉진, 항-피로 및 운동수행능력 향상에 관한 새로운 용도 WO2011145909A2 (ko)

Priority Applications (5)

Application Number Priority Date Filing Date Title
JP2013511120A JP5905874B2 (ja) 2010-05-20 2011-05-20 パンドラチン誘導体又はボエセンベルギアパンドラター抽出物の筋肉増加促進、抗疲労及び運動遂行能力向上に関する新たな用途
EP11783791.4A EP2572710B1 (en) 2010-05-20 2011-05-20 Novel use of panduratin derivatives or an extract of boesenbergia pandurata for promoting muscle mass growth, fighting fatigue, and enhancing exercise performance capability
CN201180029079.5A CN103037854B (zh) 2010-05-20 2011-05-20 潘多汀派生物或提琴形凹唇姜萃取物的促进增加肌肉、抗疲劳及提高运动执行能力相关新用途
US13/682,216 US9198880B2 (en) 2010-05-20 2012-11-20 Use of panduratin derivatives or an extract of Boesenbergia pandurata for promoting muscle mass growth, fighting fatigue, and enhancing exercise performance capability
US14/846,204 US9452193B2 (en) 2010-05-20 2015-09-04 Use of panduratin derivatives or an extract of Boesenbergia pandurata for enhancing muscle mass growth, fighting fatigue, and enhancing exercise performance

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2010-0047369 2010-05-20
KR1020100047369A KR101698201B1 (ko) 2010-05-20 2010-05-20 판두라틴 유도체 또는 보에센베르기아 판두라타 추출물을 포함하는 근육 증가 촉진, 항-피로 및 운동수행능력 향상용 조성물

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US13/682,216 Continuation US9198880B2 (en) 2010-05-20 2012-11-20 Use of panduratin derivatives or an extract of Boesenbergia pandurata for promoting muscle mass growth, fighting fatigue, and enhancing exercise performance capability

Publications (2)

Publication Number Publication Date
WO2011145909A2 WO2011145909A2 (ko) 2011-11-24
WO2011145909A3 true WO2011145909A3 (ko) 2012-03-29

Family

ID=44992237

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2011/003735 WO2011145909A2 (ko) 2010-05-20 2011-05-20 판두라틴 유도체 또는 보에센베르기아 판두라타 추출물의 근육 증가 촉진, 항-피로 및 운동수행능력 향상에 관한 새로운 용도

Country Status (6)

Country Link
US (2) US9198880B2 (ko)
EP (1) EP2572710B1 (ko)
JP (1) JP5905874B2 (ko)
KR (1) KR101698201B1 (ko)
CN (1) CN103037854B (ko)
WO (1) WO2011145909A2 (ko)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013172681A1 (ko) * 2012-05-16 2013-11-21 연세대학교 산학협력단 캠페리아 파비플로라 추출물 또는 플라본계 화합물의 근육 질환 예방 또는 치료 및 근 기능 개선용도
JP6126443B2 (ja) * 2012-06-08 2017-05-10 花王株式会社 骨格筋遅筋化剤
KR101695443B1 (ko) * 2013-11-29 2017-01-11 (주) 네추럴웨이 판두라틴 함유 정제 및 이의 제조 방법
KR101776001B1 (ko) * 2016-03-04 2017-09-07 (주)뉴트리 판두라틴 또는 핑거루트(보에센베르기아 판두라타) 추출물을 포함하는 골 손실 질환 치료, 예방 또는 개선용 조성물

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20080018855A (ko) * 2006-08-25 2008-02-28 연세대학교 산학협력단 판두라틴 에이 또는 그의 유도체의 신규한 용도
KR20090093477A (ko) * 2008-02-29 2009-09-02 (주)아모레퍼시픽 카엠페리아 판두라타 추출물을 함유한 피부 질환 예방 또는개선을 위한 조성물
KR20100040270A (ko) * 2008-10-09 2010-04-19 (주)뉴트리 판두라틴 유도체 또는 보에센베르기아 판두라타 추출물의 신규한 용도

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005089384A (ja) * 2003-09-18 2005-04-07 Kao Corp 持久力向上剤
JP2007186431A (ja) * 2006-01-11 2007-07-26 Pharmish Inc 抗酸化組成物及び脳神経細胞保護用医薬組成物、抗酸化剤及び脳神経細胞保護剤、並びにそれらの使用方法
US20120065272A1 (en) * 2007-10-17 2012-03-15 Newtree Co., Ltd. Novel use of panduratin derivatives or extract of kaempferia pandurata comprising the same
JP2011507970A (ja) * 2007-12-28 2011-03-10 ザ ソーク インスティテュート フォー バイオロジカル スタディーズ 筋肉の能力および緊張を向上させるための方法
KR20090089815A (ko) 2008-02-19 2009-08-24 주식회사 유니젠 파낙스속 식물의 잎 추출물 및 파낙스속 식물의 잎 추출물 가공물의 혼합물을 함유하는 운동능력, 피로회복 및 항산화활성 증진용 조성물
JP2010195696A (ja) * 2009-02-24 2010-09-09 Ichimaru Pharcos Co Ltd 筋増強系のＡｋｔ−ｍＴＯＲ−ｐ７０Ｓ６Ｋを活性化する製剤及びその方法

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20080018855A (ko) * 2006-08-25 2008-02-28 연세대학교 산학협력단 판두라틴 에이 또는 그의 유도체의 신규한 용도
KR20090093477A (ko) * 2008-02-29 2009-09-02 (주)아모레퍼시픽 카엠페리아 판두라타 추출물을 함유한 피부 질환 예방 또는개선을 위한 조성물
KR20100040270A (ko) * 2008-10-09 2010-04-19 (주)뉴트리 판두라틴 유도체 또는 보에센베르기아 판두라타 추출물의 신규한 용도

Also Published As

Publication number Publication date
US20130344182A1 (en) 2013-12-26
US9452193B2 (en) 2016-09-27
JP5905874B2 (ja) 2016-04-20
KR101698201B1 (ko) 2017-01-19
KR20110127879A (ko) 2011-11-28
CN103037854B (zh) 2015-02-04
US20150374777A1 (en) 2015-12-31
WO2011145909A2 (ko) 2011-11-24
CN103037854A (zh) 2013-04-10
EP2572710A2 (en) 2013-03-27
JP2013532133A (ja) 2013-08-15
EP2572710B1 (en) 2018-04-11
US9198880B2 (en) 2015-12-01
EP2572710A4 (en) 2013-11-27

Similar Documents

Publication Publication Date Title
PH12014502698B1 (en) Improved antagonist antibodies against gdf-8 and uses therefor
WO2013009100A3 (ko) 탯줄 추출물의 제조방법 및 그의 용도
MY166282A (en) Human binding molecules capable of neutralizing influenza a viruses of phylogenetic group 1 and phylogenetic group 2 and influenza b viruses
WO2012072713A3 (en) Lysine demethylase inhibitors such as cyclylcyclopropanamine derivatives for use in the treatment of diseases and disorders associated with flaviviridae
DK2473189T3 (da) Fremgangsmåder til at mindske virucid aktivitet i PCV-2-sammensætninger og PCV-2-sammensætninger med forbedret immunogenicitet.
BR112013030321A2 (pt) composição de vacina, método para preparar a composição de vacina, uso da composição de vacina, método para imunizar um porco, cepa de vacina contra csfv e uso de uma célula no cultivo de uma cepa de vacina contra csfv.
WO2012051111A3 (en) Human oncostatin m antibodies and methods of use
WO2013093096A8 (en) Ellagitannins rich extracts composition in sexual wellness
EA201490024A1 (ru) Наполненные силиконовые композиции, их получение и применение
AU2016216741A1 (en) Compositions and methods of use of an inappetance-controlling compound
WO2013067531A3 (en) Methods of using microrna 195 in providing neuroprotection
WO2011145909A3 (ko) 판두라틴 유도체 또는 보에센베르기아 판두라타 추출물의 근육 증가 촉진, 항-피로 및 운동수행능력 향상에 관한 새로운 용도
SA113340494B1 (ar) تركيبة لعلاج اضطرابات أيضية
WO2013055068A3 (ko) 구기자와 솔잎의 혼합 추출물을 유효성분으로 함유하는 레티노익산 수용체의 활성화를 통한 항노화용 조성물
WO2014145236A3 (en) The use of sdf-1 to mitigate scar formation
WO2011005666A3 (en) Methods for treating hydrocarbon-bearing formations with fluorinated acid compositions
WO2013059233A3 (en) Thermoresponsive compositions for dermatological use and methods thereof
EP2596787A4 (en) NEW USE OF HESPERETIN
WO2011140226A3 (en) Compositions comprising extracts of southernwood and an amine compound
WO2013068851A3 (en) Pesticide composition having improved rainfastness
WO2014080015A3 (en) Hair growth compositions and methods
NZ723206A (en) A method of improving liver function
WO2012016228A3 (en) Compositions and methods for mitigating adverse effects of exposure to chlorinating and/or brominating agents
EA201500274A1 (ru) Пищевой концентрат в форме геля и способ его приготовления
WO2012096463A3 (ko) 복합 생약 추출물을 유효성분으로 함유하는 알러지성 또는 비알러지성 피부 질환의 예방 및 개선용 조성물 및 이의 용도

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 201180029079.5

Country of ref document: CN

ENP Entry into the national phase

Ref document number: 2013511120

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2011783791

Country of ref document: EP

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11783791

Country of ref document: EP

Kind code of ref document: A2